Product Description
Discover a blue-ribbon solution with Tacrolimus Capsules IP 2.0 mg, now available on sale for a limited time. This exceptional immunosuppressant is noteworthy for its proven clinical efficacy and consistent compliance with Indian Pharmacopoeia standards. Each strip contains 10 fresh capsules, precisely dosed to 2.0 mg per capsule, secured in high-quality aluminium-PVC blister packs, maintaining scarcity and effectiveness. Suitable for both adult and pediatric patients as advised by a physician, this product is distributed by a leading exporter. Prescription required. For clinical and hospital use only.
Targeted Immunosuppression: Key Advantages
Tacrolimus Capsules IP 2.0 mg are primarily indicated to prevent organ transplant rejection, ensuring a robust defense against immune-mediated damage. Administered orally, they provide a convenient option for hospital and clinical applications. The main site of action is the immune system, where Tacrolimus acts to suppress immune responses effectively. Primary competitive advantages include IP compliance, a blue-ribbon efficacy profile, and a proven safety record, making it a notable choice in transplantation therapy.
Streamlined Supply: Global Handover & Shipment
With a reliable supply ability, Tacrolimus Capsules IP 2.0 mg are swiftly shipped from the domestic market in India to global destinations. As a leading exporter and distributor, we ensure every shipment is handed over efficiently and delivered within committed timelines. Our main export markets span worldwide, catering to demands in clinics and hospitals with fresh inventory. Seamless packaging, documentation, and logistics further guarantee timely delivery to wholesalers and traders.
FAQs of Tacrolimus Capsules IP 2.0 mg:
Q: How should Tacrolimus Capsules IP 2.0 mg be used?
A: Tacrolimus Capsules IP 2.0 mg should be taken orally as prescribed by a physician. Dosage is tailored based on individual needs, usually to prevent organ transplant rejection.
Q: What are the primary benefits of using Tacrolimus Capsules IP 2.0 mg?
A: The capsules provide effective immunosuppression, significantly reducing the risk of organ transplant rejection, and offer a safe, notable, and compliant solution for both adult and pediatric patients.
Q: When is Tacrolimus Capsules IP 2.0 mg indicated?
A: This medication is indicated primarily for the prevention of organ rejection in patients undergoing organ transplantation, based on medical guidance.
Q: Where is Tacrolimus Capsules IP 2.0 mg exported from and to which markets?
A: Tacrolimus Capsules IP 2.0 mg is exported from India and is available for export to clinics, hospitals, and distributors across worldwide markets.
Q: What is the process for storage and shelf life of Tacrolimus Capsules?
A: The capsules should be stored below 25C, protected from moisture and light. They have a shelf life of 24 months when stored as recommended.
Q: Are there any specific precautions or contraindications?
A: Tacrolimus Capsules must be used under strict medical supervision. They are contraindicated in individuals with known hypersensitivity to tacrolimus or its excipients, and caution is required during pregnancy (Category C).